NDC 70518-3780-01 - HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3780
- Requested NDC
- 70518-3780-01
- Package NDCs from labels
- 70518-3780-0, 70518-3780-1, 70518-3780-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2025-05-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE TABLETS, USP Rx only | REMEDYREPACK INC. | 2025-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3780-0 | HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 4 | |
| 70518-3780-1 | HYDROCHLOROTHIAZIDE | 30 in 1 BLISTER PACK | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3780 | HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 4 | Current NDC, 2 package rows | 20250508_1570f1ad-8372-477f-89c3-8c9ce01e27d1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Benicar HCT | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 881a1c32-c209-4038-9c5e-c5e46c6e0546 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Tribenzor | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 2f56d0bc-236b-41a0-9fc0-21cdfea8d890 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b56a3559-6eb2-4a8d-a9a4-232d2ff0febe | 2023-06-29 | Warnings, Adverse reactions | 197770 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Bryant Ranch Prepack | b7d6f322-6415-4952-a2d4-7f46aca8af9d | 2023-06-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | cf088009-203e-4d70-b56e-b4062cf3fcd8 | 2023-05-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| benazepril hydrochloride and hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Padagis US LLC | 3e2d3974-38b0-49d0-8020-f74107584724 | 2023-05-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 8cc154c2-2ed2-4d7c-95a5-e2946393270c | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1b72ecfd-a08d-48c5-a853-d3bc9ff882f1 | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Amneal Pharmaceuticals of New York LLC | d5a1db33-3046-407c-a557-6b41642164a9 | 2023-05-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 460f922c-1fda-44a5-889e-d7009883176b | 2023-05-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 5605f105-f7ec-473f-8beb-9e8955e8e26e | 2023-04-28 | Warnings, Adverse reactions | ANDA085182 310798 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | 3ba1f9f9-0037-4522-8605-e27dc8552b5b | 2023-04-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 69c41abb-75f4-429b-905a-1ce967924aee | 2023-04-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 3464be28-5bab-4642-9d9b-8b425822dd07 | 2023-04-01 | Warnings, Adverse reactions | ANDA085182 310798 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Exelan Pharmaceuticals, Inc. | c40b15ec-6083-4778-bca8-3e895e5694e1 | 2023-03-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | afdf1170-25a0-496d-b293-36ee0db2cd1e | 2023-03-01 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e | 2023-02-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ef100fa1-dd63-4287-8543-480a82ace168 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f1ef2a2c-7b8d-4127-8f47-29e430fba70b | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 54224596-325d-473e-adb5-1c86857aba34 | 2023-02-04 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.